Published on
August 22, 2024
- 15:49 GMT
Six-month interim report (Q2) 2024
Company release No. 16/2024 ALK delivers 21% organic revenue growth with an operating profit margin of 19% in Q2 (unaudited) Revenue growth was driven by a continued strong momentum in tablet sales, and improved performance of injection- and drop-based …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
